Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Taverna

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Bacteriology|September 1, 1996
Generation of an endogenous DNA-methylating agent by nitrosation in Escherichia coliP Taverna, B Sedgwick
Minerva Medica|June 9, 1970
[Clinical trial of a new tranquilizing agent: trioxazine]P Taverna, G Ferrari
Minerva Medica|October 20, 1971
[Clinico-statistical study of the action at the psychological-operative level of an association of glutamine and GABA in normal subjects and patients with slight mental insufficiency]T Mille, P Taverna
Rivista Di Neurologia|July 1, 1980
[Epilepsy and television. Case report]E Magrotti, G L Lazzati Crespi, P Taverna
Cancer Treatment Reviews|December 1, 1988
Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapyM D'Incalci, L Citti, P Taverna, et al.
Carcinogenesis|September 1, 1994
Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacityP Taverna, J Hansson, K J Scanlon, et al.
Biochemical and Biophysical Research Communications|May 29, 1992
Expression of E. coli tag gene encoding 3-methyladenine glycosylase I in NIH-3T3 murine fibroblastsP Taverna, E Garattini, L Citti, et al.
Anti-Cancer Drugs|August 1, 1992
Influence of O6-methylguanine on DNA damage and cytotoxicity of temozolomide in L1210 mouse leukemia sensitive and resistant to chloroethylnitrosoureasP Taverna, C V Catapano, L Citti, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screenP Taverna, L Liu, A J Hanson, et al.
Anti-Cancer Drugs|October 1, 1994
Interferon-beta does not change the level of O6-alkylguanine-DNA alkyltransferase in cancer patients' lymphocytesM Bonfanti, P Taverna, C Mangioni, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Bacteriology|September 1, 1996
Generation of an endogenous DNA-methylating agent by nitrosation in Escherichia coliP Taverna, B Sedgwick
Minerva Medica|June 9, 1970
[Clinical trial of a new tranquilizing agent: trioxazine]P Taverna, G Ferrari
Minerva Medica|October 20, 1971
[Clinico-statistical study of the action at the psychological-operative level of an association of glutamine and GABA in normal subjects and patients with slight mental insufficiency]T Mille, P Taverna
Rivista Di Neurologia|July 1, 1980
[Epilepsy and television. Case report]E Magrotti, G L Lazzati Crespi, P Taverna
Cancer Treatment Reviews|December 1, 1988
Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapyM D'Incalci, L Citti, P Taverna, et al.
Carcinogenesis|September 1, 1994
Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacityP Taverna, J Hansson, K J Scanlon, et al.
Biochemical and Biophysical Research Communications|May 29, 1992
Expression of E. coli tag gene encoding 3-methyladenine glycosylase I in NIH-3T3 murine fibroblastsP Taverna, E Garattini, L Citti, et al.
Anti-Cancer Drugs|August 1, 1992
Influence of O6-methylguanine on DNA damage and cytotoxicity of temozolomide in L1210 mouse leukemia sensitive and resistant to chloroethylnitrosoureasP Taverna, C V Catapano, L Citti, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screenP Taverna, L Liu, A J Hanson, et al.
Anti-Cancer Drugs|October 1, 1994
Interferon-beta does not change the level of O6-alkylguanine-DNA alkyltransferase in cancer patients' lymphocytesM Bonfanti, P Taverna, C Mangioni, et al.
Pageof 3